Status:
COMPLETED
Transcriptomic Study of ER 4017 Topical Application in Elderly Subject
Lead Sponsor:
L'Oreal
Conditions:
Aging
Eligibility:
MALE
60-75 years
Phase:
NA
Brief Summary
The stratum corneum (SC) is the superficial layer of the epidermis situated at the interface between the body and its outside environment. Its strategic position confers it a crucial role of protectio...
Detailed Description
Structural modifications of the superficial dermis during the aging process associated to alterations in the GAG- and PG profile appear to impact the quality of the dermal epidermal junction (DEJ). Pr...
Eligibility Criteria
Inclusion
- Phototype I to III
- Healthy skin on studied skin areas
- Subject having freely given his informed written consent.
- Cooperative subject, aware of the necessity to attend all the scheduled appointments during the study.
- Negative serology for HIV, hepatitis B and hepatitis C
- No past or present history of allergy linked either to one of the ingredients of the study cosmetic cream tested or to xylocaïne (anesthesia).
Exclusion
- Cutaneous disease or previous malignant cutaneous lesion on the tested zones.
- Any treatment able to act on blood coagulation and homeostasis.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00818545
Start Date
November 1 2007
End Date
March 1 2008
Last Update
January 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche bioclinique -Hopital st louis
Paris, France, 75010